Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-VCAM-1 Antibody (8X486) is a Rabbit antibody targeting VCAM-1. Anti-VCAM-1 Antibody (8X486) can be used in ELISA.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μL | $268 | 7-10 days |
| Description | Anti-VCAM-1 Antibody (8X486) is a Rabbit antibody targeting VCAM-1. Anti-VCAM-1 Antibody (8X486) can be used in ELISA. |
| Synonyms | VCAM-1, vascular cell adhesion molecule 1, INCAM-100, CD106 |
| Ig Type | Rabbit IgG |
| Clone | 8X486 |
| Reactivity | Mouse |
| Specificity | Mouse VCAM-1/CD106 No cross-reactivity in ELISA with Human VCAM1 Human ICAM1 Human ICAM2 Human ICAM3 Human SELL Human SELP |
| Application | |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Mouse VCAM-1 / CD106 (rM VCAM-1 / CD106; TMPY-01830; NP_035823.3; Met1-Glu698). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | Vascular cell adhesion molecule 1 (VCAM-1), also known as CD106, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Mouse VCAM-1 / CD106 protein (TMPY-01830) |
| Antigen Species | Mouse |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.